Fund profile
Fund manager
Total assets
$401.22 mm
Liabilities
$540.22 k
Net assets
$400.68 mm
Number of holdings
109.00
109 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
UNH Unitedhealth Group Inc | 36.32 mm | 68.99 k shares | 9.06 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 32.21 mm | 55.26 k shares | 8.04 | Common equity | Long | USA |
FIXED INC CLEARING CORP.REPO
Fixed Income Clearing Corp
|
23.36 mm | 23.36 mm principal | 5.83 | Repurchase agreement | Long | USA |
ABBV Abbvie Inc | 17.92 mm | 115.65 k shares | 4.47 | Common equity | Long | USA |
BSX Boston Scientific Corp. | 17.25 mm | 298.31 k shares | 4.30 | Common equity | Long | USA |
MRK Merck & Co Inc | 16.94 mm | 155.39 k shares | 4.23 | Common equity | Long | USA |
AMGN AMGEN Inc. | 14.68 mm | 50.97 k shares | 3.66 | Common equity | Long | USA |
ABT Abbott Laboratories | 14.10 mm | 128.07 k shares | 3.52 | Common equity | Long | USA |
DHR Danaher Corp. | 12.19 mm | 52.70 k shares | 3.04 | Common equity | Long | USA |
SYK Stryker Corp. | 9.93 mm | 33.16 k shares | 2.48 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 9.75 mm | 120.37 k shares | 2.43 | Common equity | Long | USA |
ISRG Intuitive Surgical Inc | 9.58 mm | 28.40 k shares | 2.39 | Common equity | Long | USA |
ELV Elevance Health Inc | 9.17 mm | 19.44 k shares | 2.29 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 8.66 mm | 16.32 k shares | 2.16 | Common equity | Long | USA |
COR Cencora Inc. | 8.65 mm | 42.10 k shares | 2.16 | Common equity | Long | USA |
MCK Mckesson Corporation | 8.11 mm | 17.51 k shares | 2.02 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 7.65 mm | 18.79 k shares | 1.91 | Common equity | Long | USA |
JNJ Johnson & Johnson | 7.54 mm | 48.08 k shares | 1.88 | Common equity | Long | USA |
BIIB Biogen Inc | 7.38 mm | 28.53 k shares | 1.84 | Common equity | Long | USA |
BDX Becton Dickinson & Co. | 6.47 mm | 26.54 k shares | 1.62 | Common equity | Long | USA |
Cigna Holding Co | 6.42 mm | 21.45 k shares | 1.60 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 5.54 mm | 6.31 k shares | 1.38 | Common equity | Long | USA |
PFE Pfizer Inc. | 5.50 mm | 191.21 k shares | 1.37 | Common equity | Long | USA |
HUM Humana Inc. | 4.85 mm | 10.60 k shares | 1.21 | Common equity | Long | USA |
Novo Nordisk A/S
|
4.80 mm | 46.29 k shares | 1.20 | Common equity | Long | Denmark |
Alcon Inc
|
4.77 mm | 61.09 k shares | 1.19 | Common equity | Long | Switzerland |
Medtronic PLC
|
4.47 mm | 54.25 k shares | 1.12 | Common equity | Long | Ireland |
ARGX Argen X SE | 4.23 mm | 11.12 k shares | 1.06 | Common equity | Long | Netherlands |
HCA HCA Healthcare Inc | 4.04 mm | 14.92 k shares | 1.01 | Common equity | Long | USA |
CNC Centene Corp. | 3.89 mm | 52.40 k shares | 0.97 | Common equity | Long | USA |
COO Cooper Companies, Inc. | 3.55 mm | 9.37 k shares | 0.89 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 2.95 mm | 30.60 k shares | 0.74 | Common equity | Long | USA |
IDXX Idexx Laboratories, Inc. | 2.87 mm | 5.16 k shares | 0.72 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 2.78 mm | 14.06 k shares | 0.69 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 2.67 mm | 7.58 k shares | 0.67 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 2.41 mm | 25.02 k shares | 0.60 | Common equity | Long | USA |
DXCM Dexcom Inc | 2.39 mm | 19.27 k shares | 0.60 | Common equity | Long | USA |
MRNA Moderna Inc | 2.25 mm | 22.61 k shares | 0.56 | Common equity | Long | USA |
A Agilent Technologies Inc. | 2.24 mm | 16.14 k shares | 0.56 | Common equity | Long | USA |
GEHC GE HealthCare Technologies Inc | 2.24 mm | 28.92 k shares | 0.56 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 2.09 mm | 7.63 k shares | 0.52 | Common equity | Long | USA |
PEN Penumbra Inc | 2.03 mm | 8.09 k shares | 0.51 | Common equity | Long | USA |
Sanofi SA
|
1.83 mm | 18.41 k shares | 0.46 | Common equity | Long | France |
ALNY Alnylam Pharmaceuticals Inc | 1.68 mm | 8.78 k shares | 0.42 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 1.66 mm | 17.98 k shares | 0.41 | Common equity | Long | USA |
AstraZeneca PLC
|
1.59 mm | 11.75 k shares | 0.40 | Common equity | Long | UK |
BAX Baxter International Inc. | 1.58 mm | 40.87 k shares | 0.39 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 1.54 mm | 33.40 k shares | 0.38 | Common equity | Long | USA |
STERIS PLC
|
1.51 mm | 6.87 k shares | 0.38 | Common equity | Long | Ireland |
IQV IQVIA Holdings Inc | 1.42 mm | 6.12 k shares | 0.35 | Common equity | Long | USA |
AVTR Avantor Inc. | 1.39 mm | 60.70 k shares | 0.35 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 1.33 mm | 22.05 k shares | 0.33 | Common equity | Long | Cayman Islands |
MASI Masimo Corp | 1.22 mm | 10.39 k shares | 0.30 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 1.22 mm | 19.38 k shares | 0.30 | Common equity | Long | USA |
INCY Incyte Corp. | 1.19 mm | 18.96 k shares | 0.30 | Common equity | Long | USA |
DGX Quest Diagnostics, Inc. | 1.07 mm | 7.75 k shares | 0.27 | Common equity | Long | USA |
QIAGEN NV
|
1.05 mm | 24.24 k shares | 0.26 | Common equity | Long | Netherlands |
LH Laboratory Corp. Of America Holdings | 1.04 mm | 4.57 k shares | 0.26 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 1.00 mm | 21.80 k shares | 0.25 | Common equity | Long | Canada |
RGEN Repligen Corp. | 1.00 mm | 5.58 k shares | 0.25 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 987.53 k | 66.28 k shares | 0.25 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 882.53 k | 6.70 k shares | 0.22 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 880.62 k | 17.41 k shares | 0.22 | Common equity | Long | USA |
TECH Bio-Techne Corp | 869.28 k | 11.27 k shares | 0.22 | Common equity | Long | USA |
MTD Mettler-Toledo International, Inc. | 830.88 k | 685.00 shares | 0.21 | Common equity | Long | USA |
BeiGene Ltd
|
827.13 k | 4.59 k shares | 0.21 | Common equity | Long | Cayman Islands |
INSP Inspire Medical Systems Inc | 808.02 k | 3.97 k shares | 0.20 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 747.57 k | 10.11 k shares | 0.19 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 702.12 k | 9.54 k shares | 0.18 | Common equity | Long | USA |
Daiichi Sankyo Co Ltd
|
654.30 k | 23.90 k shares | 0.16 | Common equity | Long | Japan |
CTLT Catalent Inc. | 643.71 k | 14.33 k shares | 0.16 | Common equity | Long | USA |
Genmab A/S
|
641.21 k | 2.01 k shares | 0.16 | Common equity | Long | Denmark |
MRTX Mirati Therapeutics Inc | 635.62 k | 10.82 k shares | 0.16 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 628.03 k | 14.81 k shares | 0.16 | Common equity | Long | USA |
Immunocore Holdings PLC
|
586.60 k | 8.59 k shares | 0.15 | Common equity | Long | UK |
KRTX Karuna Therapeutics Inc | 571.30 k | 1.81 k shares | 0.14 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 567.27 k | 10.14 k shares | 0.14 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 463.38 k | 9.69 k shares | 0.12 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 454.23 k | 20.01 k shares | 0.11 | Common equity | Long | USA |
Merus NV
|
441.29 k | 16.05 k shares | 0.11 | Common equity | Long | Netherlands |
PTGX Protagonist Therapeutics Inc | 438.51 k | 19.12 k shares | 0.11 | Common equity | Long | USA |
Genmab A/S
|
436.27 k | 13.70 k shares | 0.11 | Common equity | Long | Denmark |
MLTX MoonLake Immunotherapeutics - Ordinary Shares | 418.26 k | 6.93 k shares | 0.10 | Common equity | Long | Cayman Islands |
GPCR Structure Therapeutics Inc | 415.47 k | 10.19 k shares | 0.10 | Common equity | Long | Cayman Islands |
Roivant Sciences Ltd
|
410.06 k | 36.52 k shares | 0.10 | Common equity | Long | Bermuda |
ABMD Abiomed Inc | 405.89 k | 2.13 k shares | 0.10 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 377.68 k | 12.60 k shares | 0.09 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 375.23 k | 13.62 k shares | 0.09 | Common equity | Long | USA |
NVST Envista Holdings Corp | 367.73 k | 15.28 k shares | 0.09 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 354.92 k | 12.38 k shares | 0.09 | Common equity | Long | USA |
Novocure Ltd
|
300.59 k | 20.13 k shares | 0.08 | Common equity | Long | Jersey |
GH Guardant Health Inc | 280.54 k | 10.37 k shares | 0.07 | Common equity | Long | USA |
AC Immune SA
|
265.75 k | 53.15 k shares | 0.07 | Common equity | Long | Switzerland |
VKTX Viking Therapeutics Inc | 221.85 k | 11.92 k shares | 0.06 | Common equity | Long | USA |
MORF Morphic Holding Inc | 153.47 k | 5.31 k shares | 0.04 | Common equity | Long | USA |
PRME Prime Medicine Inc | 146.21 k | 16.50 k shares | 0.04 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings Inc | 113.39 k | 12.42 k shares | 0.03 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 93.55 k | 6.44 k shares | 0.02 | Common equity | Long | USA |
CureVac NV
|
85.44 k | 20.30 k shares | 0.02 | Common equity | Long | Netherlands |
IMRX Immuneering Corp - Ordinary Shares | 84.58 k | 11.51 k shares | 0.02 | Common equity | Long | USA |
TNYA Tenaya Therapeutics Inc | 63.47 k | 19.59 k shares | 0.02 | Common equity | Long | USA |
NAUT Nautilus Biotechnology Inc | 41.50 k | 13.88 k shares | 0.01 | Common equity | Long | USA |
CONTRA ABIOMED INC | 30.15 k | 11.08 k shares | 0.01 | Equity derivative | N/A | USA |
RPID Rapid Micro Biosystems Inc - Ordinary Shares | 12.07 k | 16.32 k shares | 0.00 | Common equity | Long | USA |
CONTRA FREQUENCY THERA | 268.46 | 19.74 k shares | 0.00 | Equity derivative | N/A | USA |
NUVB Nuvation Bio Inc - Ordinary Shares | 208.32 | 3.47 k shares | 0.00 | Equity derivative | N/A | USA |
CMAX CareMax Inc - Ordinary Shares | 49.95 | 3.65 k shares | 0.00 | Equity derivative | N/A | USA |
PURCHASED USD / SOLD GBP
Bank of New York Mellon
|
-20.49 k | 1.00 contracts | -0.01 | DFE | N/A | USA |
PURCHASED USD / SOLD EUR
Westpac Banking Corp.
|
-104.80 k | 1.00 contracts | -0.03 | DFE | N/A | USA |